Stay updated on Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:32:04.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the government funding status notice and related operating-status links from the page.
    Difference
    0.4%
    Check dated 2025-11-18T06:49:37.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The changes between the old and new pages are non-significant, with core study information unchanged and only minor UI or formatting adjustments observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T20:42:43.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Only minor UI/layout differences are visible between the screenshots. No core content like study details, eligibility criteria, or outcomes appears to have changed.
    Difference
    0.1%
    Check dated 2025-10-27T14:58:18.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    No significant changes detected.
    Difference
    0.5%
    Check dated 2025-10-13T07:28:15.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Core content updated with a government-operating-status notice and a version upgrade to v3.2.0, replacing the previous v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T04:49:57.000Z thumbnail image

Stay in the know with updates to Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page.